Quale sarebbe il prezzo per Genix Pharmaceuticals Corporation (GENPF)

Il prezzo per Genix Pharmaceuticals Corporation (GENPF) è $0.0138

Qual è la capitalizzazione di mercato per Genix Pharmaceuticals Corporation (GENPF)

La capitalizzazione di mercato per Genix Pharmaceuticals Corporation (GENPF) è $844.89K

Genix Pharmaceuticals Corporation (GENPF) Prezzo e Capitalizzazione di Mercato

Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds. Renochlor: A nutritional supplement formulated to support the revitalization and maintenance of kidney health and function. Sucanon: An insulin sensitizer designed to reduce blood sugar by improving the sensitivity of muscle, fat, and liver cells to insulin. Beyond these, Genix Pharmaceuticals also offers a wide range of other nutraceuticals and pharmaceutical items. This selection includes supplements such as bee propolis capsules, liquid calcium softgels, seal oil softgels, marine lipid softgels, lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, alongside ophthalmic products like eye ointments and drops. The company operated under the name Alta Natural Herbs & Supplements Ltd. until it adopted its current identity, Genix Pharmaceuticals Corporation, in June 2019.

Il prezzo per GENPF	Attivo B	Capitalizzazione del mercato a B	Risultati
$89,070.46 $844.89K	NVDA	$5.453T	+645,437,997.45%
$73,309.48 $844.89K	AAPL	$4.488T	+531,228,007.95%
$67,965.98 $844.89K	GOOG	$4.161T	+492,507,036.59%
$60,405.24 $844.89K	MSFT	$3.698T	+437,719,016.59%
$46,312.85 $844.89K	AMZN	$2.835T	+335,600,262.38%

Il prezzo per GENPF

Attivo B

Capitalizzazione del mercato a B

Risultati

$89,070.46 $844.89K